ClinicalTrials.Veeva

Menu
B

BVL Clinical Research | Liberty, MO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Duvakitug
Vedolizumab
ABX464
Ustekinumab
Adalimumab
TAK-279
Efavaleukin Alfa
TEV-48574
Tofacitinib
BI 706321

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 12 total trials

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease (STARSCAPE-2)

This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in p...

Enrolling
Crohn's Disease
Drug: Duvakitug
Drug: Placebo

This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in par...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: Duvakitug

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ)...

Active, not recruiting
Crohn's Disease
Drug: Vedolizumab
Drug: Adalimumab

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moder...

Active, not recruiting
Ulcerative Colitis
Drug: Tofacitinib
Drug: Vedolizumab

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate t...

Enrolling
Crohn's Disease
Drug: Placebo
Drug: TAK-279

The primary objective of the study is to evaluate the efficacy of 2 different maintenance dose regimens of TEV-48574 subcutaneous (sc) administered e...

Active, not recruiting
Colitis, Ulcerative
Crohn Disease
Drug: TEV-48574 Dose Regiment B
Drug: TEV-48574 Dose Regimen A

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once d...

Active, not recruiting
Ulcerative Colitis
Drug: ABX464
Drug: Placebo

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate...

Enrolling
Crohn's Disease
Drug: Duvakitug
Drug: Placebo

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of du...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: Duvakitug

Trial sponsors

Sanofi logo
Takeda logo
A
Amgen logo
Boehringer Ingelheim logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems